IFLScience on MSN
First Targeted Treatment For Dangerous Liver Disease Could Come From An Unexpected Source
Scientists could be on course to develop the first treatment with a chance of controlling and even reversing liver fibrosis, ...
Akeso, Inc. (($HK:9926)) announced an update on their ongoing clinical study. Akeso, Inc. is conducting a Phase III clinical study titled A Phase ...
Hepatocellular carcinoma (HCC) represents a leading cause of cancer-related mortality globally. The advent of immunotherapy, particularly immune checkpoint ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback